Cronkhite-Canada Syndrome: A Comprehensive Review of Its Pathophysiology, Clinical Manifestations, and Current Therapeutic Approaches
Bibliographic record
Abstract
Cronkhite-Canada Syndrome (CCS) is a rare, non-hereditary gastrointestinal polyposis syndrome characterized by a complex constellation of clinical features, including diffuse gastrointestinal polyposis, ectodermal abnormalities, and profound malabsorption. Although its exact etiology remains elusive, an autoimmune pathogenesis has been increasingly suspected, with reports of immune-mediated damage contributing to epithelial dysfunction. Patients with CCS typically present with chronic diarrhea, weight loss, protein-losing enteropathy, and alopecia, in addition to nail dystrophy and cutaneous hyperpigmentation. Histopathological examination of intestinal polyps reveals hamartomatous and inflammatory characteristics, with a predilection for the stomach and colon. The diagnosis of CCS relies on a combination of endoscopic findings, histopathological analysis, and the exclusion of other polyposis syndromes. Given the high morbidity and potential for malignant transformation, early recognition and intervention are crucial. Treatment strategies are primarily supportive, aiming to manage nutritional deficiencies and control inflammation. Glucocorticoids, immunosuppressive agents, and proton pump inhibitors have been utilized with varying success, while emerging therapies targeting immune dysregulation offer potential novel avenues for management. Despite therapeutic advancements, the prognosis remains guarded, with a substantial risk of relapse and complications such as gastrointestinal bleeding and malignancy. This review aims to provide a detailed analysis of the pathophysiology, clinical spectrum, diagnostic modalities, and therapeutic strategies for CCS, emphasizing recent insights into its immunopathogenesis and emerging treatment options.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.001 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.003 | 0.002 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".